IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q1 2025 Holdings

Filed 2025-05-15 | 57 holdings | $984.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$43.0M76,9004.4%
Vera Therapeutics Inc(VERA)CL A92337R101$45.6M1,898,8044.6%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$51.7M4,212,2705.3%
HCA Healthcare Inc(HCA)COM40412C101$52.7M152,5025.4%
Invesco QQQ TR(QQQ)PutUNIT SER 146090E103$58.0M123,6005.9%
GSK PLC(GSK)SPONSORED ADR37733W204$101.6M2,623,24610.3%
Natera Inc(NTRA)COM632307104$126.4M893,72112.8%
PreviousPage 2 of 2